Outcomes of macular hole surgery in patients treated intraoperatively for retinal breaks and/or lattice degeneration

Retina

Volumn 27, Issue 9, 2007, Pages 1243-1248

  Hwang, John ^a   Escariao, Paulo ^a,b   Iranmanesh, Reza ^a   Tosi, Gian Marco ^a,c   Chang, Stanley ^a  

^a Edward S Harkness Eye Institute   (United States)

^b FUNDAÇÃO ALTINO VENTURA   (Brazil)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Macular hole; Retinal break; Retinal tear

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LASER COAGULATION; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD REVIEW; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; RETINA DEGENERATION; RETINA INJURY; RETINA MACULA HOLE; RETINA SURGERY; RETROSPECTIVE STUDY; REVIEW; RISK REDUCTION; SURGICAL PATIENT; SURGICAL RISK; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; DRAINAGE; FEMALE; FLUOROCARBONS; HUMANS; INTRAOPERATIVE CARE; LASER COAGULATION; MALE; MIDDLE AGED; RETINAL DEGENERATION; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 36749055238     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318065364b     Document Type: Review

References (56)

1. la Cour M, Friss J. Macular holes: classification, epidemiology, natural history and treatment. Acta Ophthalmol Scand 2002;80:579-587.
2. Rahmani B, Tielsch JM, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population. Ophthalmology 1996;103:1721-1726.
3. Kang HK, Chang AA, Beaumont PE. The macular hole: report of an Australian surgical series and meta-analysis of the literature. Clin Exp Ophthalmol 2000;28:298-308.
4. Casuso LA, Scott IU, Flynn HW Jr, et al. Long-term follow-up of unoperated macular holes. Ophthalmology 2001;108:1150-1155.
5. Smiddy WE, Flynn HW Jr. Pathogenesis of macular holes and therapeutic implications. Am J Ophthalmol 2004;137:525-537.
6. Benson WE, Cruickshanks KC, Fong DS, et al. Surgical management of macular holes: a report by the American Academy of Ophthalmology. Ophthalmology 2001;108:1328-1335.
7. Gass JD. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol 1988;106:629-639.
8. Johnson RN, McDonald HR, Lewis H, et al. Traumatic macular hole: observations, pathogenesis, and results of vitrectomy surgery. Ophthalmology 2001;108:853-857.
9. Park SS, Marcus DM, Duker JS, et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology 1995;102:775-781.
10. Wendel RT, Patel AC, Kelly NE, et al. Vitreous surgery for macular holes. Ophthalmology 1993;100:1671-1676.
11. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol 1991;109:654-659.
12. Lansing MB, Glaser BM, Liss H, et al. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full thickness macular holes. Ophthalmology 1993;100:868-871.
13. Kim JW, Freeman WR, El-Haig W, et al. Baseline characteristics, natural history, and risk factors to progression in eyes with stage 2 macular holes: results from a prospective randomized clinical trial. Ophthalmology 1995;102:1818-1829.
14. Wells JA, Gregor ZJ. Surgical treatment of full-thickness macular holes using autologous serum. Eye 1996;10:593-599.
15. Orrellana J, Lieberman RM. Stage III macular hole surgery. Br J Ophthalmol 1993;77:555-558.
16. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes: preliminary anatomic results of a multicentre prospective randomized study. Retina 1993;13:296-301.
17. Thompson JT, Sjaarda RN, Glaser BM, Murphy RP. Increased intraocular pressure after macular hole surgery. Am J Ophthalmol 1996;121:615-622.
18. Thompson JT, Smiddy WE, Williams GA, et al. Comparison of recombinant transforming growth factor beta-2 and placebo as an adjunctive agent for macular hole surgery. Ophthalmology 1998;105:700-706.
19. Gaudric A, Massin P, Paques M, et al. Autologous platelet concentrate for the treatment of full thickness macular holes. Graefes Arch Clin Exp Ophthalmol 1995;233:549-554.
20. Iwasaki T, Sanda A, Yamamoto K, Okade A, Usui NM. The use of fibrin tissue adhesive in the treatment of macular holes. Invest Ophthalmol Vis Sci 1995;36:1050-1056.
21. Thompson JT, Glaser BM, Sjaarda RN, et al. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor beta-2. Ophthalmology 1994;101:1195-1200.
22. Ryan EA, Lee S, Chern S. Use of intravitreal autologous blood to identify the posterior cortical vitreous in macular hole surgery. Arch Ophthalmol 1995;113:822-823.
23. Ruby AJ, Williams DF, Grand MG, et al. Pars plana vitrectomy for treatment of stage 2 macular holes. Arch Ophthalmol 1994;112:359-364.
24. Lewis JM, Park I, Ohji M, et al. Diamond-dusted silicone cannula for epiretinal membrane separation during vitreous surgery. Am J Ophthalmol 1997;124:552-554.
25. Glaser BM, Michels RG, Kupperman BD, et al. The effects of pars plana vitrectomy and transforming growth factor-beta 2 for the treatment of full-thickness macular holes: a prospective randomized study. Ophthalmology 1992;99:1162-1173.
26. Ryan EH, Gilbert HD. Results of surgical treatment of recent-onset full thickness idiopathic macular holes. Arch Ophthalmol 1994;112:1545-1553.
27. Tilanus MA, Deutman AF. Full-thickness macular holes treated with vitrectomy and tissue glue. Int Ophthalmol 1994;18:355-358.
28. Olsen TW, Sternberg P, Martin DF, et al. Postoperative hypopyon after intravitreal bovine thrombin for macular hole surgery. Am J Ophthalmol 1996;121:575-577.
29. Kim JW, Freeman WR, Azen SP, et al. Prospective randomized trial of vitrectomy for stage 2 macular holes. Am J Ophthalmol 1996;121:605-614.
30. Freeman WR, Azen SP, Kim JW, et al. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes: results of a multicenter randomized controlled trial. Arch Ophthalmol 1997;115:11-22.
31. Ezra E, Aylward WG, Gregor ZJ. Membranectomy and autologous serum for the retreatment of full-thickness macular holes. Arch Ophthalmol 1997;115:1276-1280.
32. Korobelnik JF, Hannouche D, Belayachi N, et al. Autologous platelet concentrate as an adjunct in macular hole surgery: a pilot study. Ophthalmology 1996;103:590-594.
33. Liggett PE, Skolik S, Horio B, et al. Human autologous serum for the treatment of full thickness macular holes: a preliminary study. Ophthalmology 1995;102:1071-1076.
34. Christmas NJ, Skolik SA, Howard MA, Saito Y, Barnstable CJ, Liggett PE. Treatment of retinal breaks with autologous serum in an experimental model. Ophthalmology 1995;102:263-271.
35. Paques M, Chastang C, Mathis A, et al. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: results of a multicentre, double-masked, randomised trial. Ophthalmology 1999;106:932-938.
36. Blumenkranz MS, O'Hana E, Shaik S, et al. Adjuvant methods in macular hole surgery: intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange. Ophthalmic Surg Lasers 2001;32:198-207.
37. Margherio RR, Margherio AR, Williams GA, Chow DR, Banach MJ. Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular hole. Arch Ophthalmol 2000;118:495-498.
38. Mester V, Kuhn F. Internal limiting membrane removal in the management of full-thickness macular hole. Am J Ophthalmol 2000;129:769-777.
39. Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S. Staining of the internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118.
40. Park DW, Sipperly JO, Sneed SR, Dugel PU, Jacobsen J. Macular hole surgery with internal limiting membrane peeling and intravitreous air. Ophthalmology 1999;106:1392-1397.
41. Brooks HL. Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology 2000;107:1939-1948.
42. Goldbaum MH, McCuen BW, Hanneken AM, Burgess SK, Chen HH. Silicone oil tamponade to seal macular holes without position restrictions. Ophthalmology 1998;105:2140-2147.
43. Jumper JM, Gallemore RP, McCuen BW, Toth CA. Features of macular hole closure in the early postoperative period using optical coherence tomography. Retina 2000;20:232-237.
44. Cheng L, Freeman WR, Ozerdem U, Song MK, Azen SP. Prevalence, correlates and natural history of epiretinal membrane surrounding idiopathic macular holes: Vitrectomy for Macular Hole Study Group. Ophthalmology 2000;107:853-859.
45. Olsen TW, Sternberg P, Capone A, et al. Macular hole surgery using thrombin activated fibrinogen and selective removal of the internal limiting membrane. Retina 1998;18:322-329.
46. Freeman WR, Azen SP. Evaluation of new techniques in macular surgery. Ophthalmology 1999;106:861-862.
47. Banker AS, Freeman WR, Kim JW, Munguia D, Azen SP. Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology 1997;104:1442-1452.
48. Tabandeh H, Chaudhry NA, Smiddy WE. Retinal detachment associated with macular hole surgery: characteristics, mechanism, and outcomes. Retina 1999;19:281-286.
49. Heier JS, Topping TM, Frederick AR Jr, et al. Visual and surgical outcomes of retinal detachment following macular hole repair. Retina 1999;19:110-115.
50. Sjaarda RN, Glaser BM, Thompson JT, Murphy RP, Hanham A. Distribution of iatrogenic retinal breaks in macular hole surgery. Ophthalmology 1995;102:1387-1392.
51. Amemiya T, Iida Y, Yoshida H. Subjective and objective ocular disturbances in reattached retina after surgery for retinal detachment, with special reference to visual acuity and metamorphopsia. Ophthalmologica 1983;186:25-30.
52. Markham RH, Chignell AH. Visual acuity after retinal detachment operations. Trans Ophthalmol Soc UK 1979;99:197-200.
53. Gass JD. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol 1995;119:752-759.
54. Ezra E, Gregor ZJ. Surgery for idiopathic full-thickness macular hole: two-year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Moorfields Macular Hole Study Group Report no. 1. Arch Ophthalmol 2004;122:224-236.
55. Chalam KV, Shah VA. Optics of wide-angle panoramic viewing system-assisted vitreous surgery. Surv Ophthalmol 2004;49:437-445.
56. Scott IU, Moraczewski AL, Smiddy WE, Flynn HW Jr, Feuer WJ. Long-term anatomic and visual acuity outcomes after initial anatomic success with macular hole surgery. Am J Ophthalmol 2003;135:633-640.